Introduction to Pharmaceutical Dosage Forms & Pharmaceutical Excipients

0.0(0)
Studied by 0 people
call kaiCall Kai
Locked
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/24

encourage image

There's no tags or description

Looks like no tags are added yet.

Last updated 3:15 PM on 8/13/26
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai
Chat

No analytics yet

Send a link to your students to track their progress

25 Terms

1
New cards

What is a dosage form?

A pharmaceutical dosage form is the physical form in which a medication is produced and dispensed for patient administration.

2
New cards

What does dosage form determine?

It determines how the drug is delivered to the body and can influence its effectiveness, stability, and patient compliance.

3
New cards

Why are pharmaceutical excipients used?

  • Protecet, support, or enhance stability of the formulation (e.g. preservatives, antioxidants etc)

  • Bulk up the formulation (drug with very small dose)

  • Improve patient acceptance (coloring, falvorings, sweeteners etc)

  • Help to improve bioavailability of active drug (disintigrants, surfactants etc)

  • Enhance overall safety and effectiveness of the formulation during its storage and use (preservatives, antioxidants etc.)

4
New cards

Explain how preservatives protect, support, and enhance stability of pharmaceutical formulations

Preservatives play a crucial role in pharmaceutical formulations by protecting the product from microbial contamination, thereby ensuring safety, efficacy, and stability throughout its shelf life. They inhibit the growth of bacteria, fungi, and other microorganisms that may enter the product during manufacturing, storage, or use; especially in multi-dose containers. This microbial protection prevents spoilage, maintains the integrity of the active ingredients, and reduces the risk of infections in patients, particularly in sensitive applications such as ophthalmic or nasal preparations. In addition to preventing microbial degradation, preservatives support overall formulation stability by preserving physical and chemical properties such as pH, color, odor, and texture. Some preservatives even exhibit antioxidant properties, indirectly protecting against oxidative degradation. By maintaining the formulation’s quality and organoleptic characteristics, preservatives enhance patient compliance and ensure the product remains both effective and acceptable for use over its intended duration. Therefore, the inclusion of appropriate preservatives is essential in many dosage forms to support and enhance the stability and safety of pharmaceutical products.

5
New cards

Explain how antioxidants protect, support, and enhance the stability of pharmaceutical formulations.

Antioxidants are important excipients in pharmaceutical formulations that protect the product from oxidative degradation, thereby supporting and enhancing its stability and shelf life. Many active pharmaceutical ingredients (APIs), especially those containing unsaturated bonds, phenolic groups, or easily oxidizable functional groups, are sensitive to oxidation when exposed to air, light, or metal ions. Oxidation can lead to the loss of potency, discoloration, formation of harmful degradation products, and changes in odor or texture. Antioxidants work by interrupting the oxidative chain reactions through different mechanisms such as scavenging free radicals, binding metal ions that catalyze oxidation, or being preferentially oxidized themselves to spare the active ingredients. By preventing such degradation, antioxidants help maintain the chemical integrity and therapeutic efficacy of the formulation. They also preserve the aesthetic and organoleptic properties of the product, making it more acceptable to patients. Overall, antioxidants play a critical role in protecting sensitive formulations, supporting their stability under storage conditions, and ensuring consistent product performance over time.

6
New cards

Excipients are used to bulk up the formulation. Explain the statement.

The statement "Excipients are used to bulk up the formulation" refers to the use of inactive ingredients (excipients, more specifically fillers or diluents or bulking agent) to increase the size, weight, and volume of a pharmaceutical dosage form, especially when the active ingredient (API) is present in a very small amount. This is important because such tiny quantities of drug substances are difficult to handle, compress into tablets, or divide into accurate doses without adding bulk.

A good example of this is the clonazepam tablet. Clonazepam is a highly potent drug, and the required therapeutic dose is usually very low, such as 0.25 mg, 0.5 mg, or 1 mg. These amounts are too small to be formulated into a tablet on their own, as the tablet would be nearly invisible, extremely fragile, and impossible to handle or manufacture accurately.

To solve this, excipients like diluents (e.g., lactose, microcrystalline cellulose) are added to "bulk up" the formulation. These excipients increase the overall mass of the tablet to a manageable size (often 100–200 mg or more), allowing it to be compressed properly, handled easily, and administered accurately. Other excipients like binders, disintegrants, lubricants, and glidants are also included to support manufacturing and ensure proper tablet disintegration and absorption in the body.

Thus, in the case of clonazepam tablets, excipients are essential not just for physical bulk, but also for ensuring dosage accuracy, tablet quality, and therapeutic effectiveness.

7
New cards

Excipients are used to Improve patient acceptance. Explain it with example.

The statement "Excipients are used to improve patient acceptance" means that excipients are added to pharmaceutical formulations to make the medication more palatable, comfortable, and convenient for patients to take, which helps improve compliance with the prescribed treatment.

For example, in oral liquid medications such as syrups or suspensions, excipients like sweeteners (e.g., sucrose, sorbitol) and flavoring agents (e.g., orange, strawberry, mint) are used to mask the bitter or unpleasant taste of the active drug. This is particularly important in pediatric formulations, where taste can greatly influence whether a child will willingly take the medication.

Take paracetamol syrup as an example. Paracetamol itself has a bitter taste, but when formulated as a syrup for children, it includes sweeteners, flavors, and sometimes coloring agents. These excipients enhance the taste, appearance, and smell, making the medication more acceptable and encouraging children to take it as prescribed.

Similarly, in tablets, film coatings made from polymers and colorants not only mask the taste and odor but also improve the appearance of the tablet, making it more appealing and easier to swallow. These features ultimately lead to better patient adherence, which is critical for the success of any therapeutic regimen.

8
New cards

Excipients are used to improve the bioavailability of active drug

ā€œExcipients are used to improve the bioavailability of the active drugā€ refers to the use of certain excipients that help enhance the rate and extent to which a drug is absorbed into systemic circulation, making it more effective. Some drugs have poor solubility, poor permeability, or are unstable in physiological environments, and the right choice of excipients can significantly improve their bioavailability.

9
New cards

Excipients are used to improve the bioavailability of active drug. Explain it with the example of surfactant

Function: Surfactants increase the solubility and enhance the wetting of poorly water-soluble drugs.

Example: In formulations containing poorly soluble drugs like cyclosporine, surfactants such as polysorbate 80 or sodium lauryl sulfate are used. These help the drug dissolve better in gastrointestinal fluids, allowing for improved absorption and thus enhanced bioavailability.

10
New cards

Excipients are used to improve the bioavailability of active drug. Explain it with the example of disintegrants

Function: Disintegrants promote the breakdown of tablets or capsules into smaller fragments in the gastrointestinal tract, increasing the surface area of the drug for dissolution.

Example: In a tablet of paracetamol, disintegrants like sodium starch glycolate or croscarmellose sodium help the tablet disintegrate quickly after ingestion, facilitating faster release and absorption of the drug, which supports improved bioavailability

11
New cards

Excipients are used to improve the bioavailability of active drug. Explain it with the example of antioxidants

Function: Antioxidants prevent the oxidative degradation of drugs, preserving their chemical stability and potency until absorption.

Example: In formulations containing vitamin A or E, which are prone to oxidation, antioxidants like butylated hydroxytoluene (BHT) or ascorbic acid are added. By maintaining the integrity of the active drug, antioxidants indirectly support bioavailability by ensuring the active form of the drug is available for absorption.

12
New cards

Excipients are used to improve the bioavailability of active drug. Explain it with the example of preservatives

Function: While their primary role is to prevent microbial contamination, preservatives also protect the formulation from degradation that can affect the availability of the active drug.

Example: In multi-dose eye drops containing timolol, preservatives like benzalkonium chloride not only maintain sterility but also enhance corneal penetration by slightly disrupting the epithelial barrier, thereby enhancing ocular bioavailability.

13
New cards

Excipients are used to enhance overall safety and effectiveness of the formulation during its storage and use. Explain

ā€œExcipients are used to enhance the overall safety and effectiveness of the formulation during its storage and useā€ highlights the crucial role excipients play beyond simply supporting the active ingredient. They help maintain the integrity, stability, sterility, and usability of pharmaceutical products, ensuring that the drug remains safe and effective throughout its shelf life and during patient use.

14
New cards

Excipients are used to enhance overall safety and effectiveness of the formulation during its storage and use. Explain with the example of antioxindants

Antioxidants protect the active drug from oxidative degradation, which can lead to the formation of harmful by-products, loss of potency, discoloration, and unpleasant odors.

Example: In formulations containing ascorbic acid (vitamin C) or unsaturated oils, antioxidants such as butylated hydroxytoluene (BHT) or sodium metabisulfite are used to prevent oxidation. This ensures that the drug remains chemically stable and safe for use until the expiry date.

15
New cards

Excipients are used to enhance overall safety and effectiveness of the formulation during its storage and use. Explain with the example of preservatives

Preservatives are added to prevent microbial contamination during storage and repeated use, especially in multi-dose containers.

Example: In ophthalmic solutions like eye drops, preservatives such as benzalkonium chloride are used to inhibit bacterial or fungal growth. This ensures that each dose remains sterile and safe, reducing the risk of eye infections.

16
New cards

Excipients are used to enhance overall safety and effectiveness of the formulation during its storage and use. Explain with the example of desiccants and moisture

Moisture-sensitive drugs require protection from humidity to maintain stability.

Example: Silica gel desiccants in tablet bottles or moisture-barrier coatings on tablets help prevent degradation of hygroscopic drugs like aspirin, ensuring the product remains effective and safe during storage.

17
New cards

Ideal Characteristics of Excipients

āœ“Chemically stable
āœ“Non-reactive
āœ“Low equipment and process sensitive
āœ“Inert to human body
āœ“Non-toxic
āœ“Acceptable with regards to organoleptic characteristics
āœ“Economical
āœ“Having efficiency in regards with the intended use

18
New cards

Excipients should be low equipment and process sensitive. Explain with examples

Pharmaceutical manufacturing involves several processes like mixing, granulation, drying, compression, and coating, which can expose excipients to heat, pressure, shear forces, and moisture. If excipients are too sensitive, they may:

•Degrade or lose their functionality

•Cause problems like sticking, clumping, or poor flow

•Lead to batch failures or inconsistent drug release

Therefore, excipients must be physically and chemically stable under typical processing conditions.

Examples:

Microcrystalline Cellulose (MCC)

MCC is a common diluent and binder used in tablets. It is thermally stable, has excellent compressibility, and is not sensitive to moisture or heat during granulation and compression. This makes it ideal for a wide range of manufacturing processes without equipment-related issues.

Starch

Starch serves as a disintegrant and binder. It is sensitive to high shear and heat, especially during wet granulation, where excessive processing can degrade starch’s binding properties. Therefore, starch requires careful process control, illustrating an excipient with some process sensitivity.

19
New cards

What are fillers?

Fillers, also called diluents, are inert excipients used in solid dosage forms (e.g., tablets, capsules) to increase bulk so the final product is of a practical size and weight for handling, manufacturing, and patient use.

20
New cards

Functions of fillers

1) Provide necessary tablet/capsule mass for very low-dose drugs. 2) Improve powder flow properties for consistent die filling. 3) Enhance compressibility and tablet strength. 4) Assist in achieving content uniformity for potent APIs.

21
New cards

Requirement of ideal fillers

1) be chemically inert; 2) be non-hygroscopic; 3) be biocompatible; 4) possess good biopharmaceutical properties (e.g. Water soluble or hydrophilic); 5) possess good technical properties (such as compressibility and dilution capacity); 6) have an acceptable taste; 7) be cheap

22
New cards

Example of fillers/diluents

Microcrystalline cellulose (MCC), Lactose (water soluble), Dicalcium phosphate (water insoluble), Starch etc.

23
New cards

Paracetamol and clonazepam have doses of 500 mg and 0.5 mg, respectively. In the formulation of a tablet dosage form, for which drug would the use of a filler be necessary? Justify your answer.

A filler (diluent) is necessary for clonazepam (0.5 mg); not for paracetamol (500 mg) purely because of dose size.

A typical tablet needs a practical mass and size for handling, compression and patient use. A 0.5 mg drug by itself would make an impractically tiny tablet, so a diluent is required to bring the tablet to workable mass.

Paracetamol at 500 mg already contributes sufficient mass, so a filler for mass is usually not required (though other excipients are often added for flow, compressibility, disintegration, etc.).

Moreover, very low-dose/high-potency drugs (like 0.5 mg clonazepam) are prone to content-uniformity problems. The drug must be homogeneously distributed through a much larger quantity of excipient. A filler provides the bulk matrix for accurate dosing.

24
New cards

What potential problems may arise due to use of an excess amount of filler? Explain.

•Too much filler increases bulk, making tablets or capsules too big for comfortable swallowing, which can reduce patient compliance.

•Certain fillers can slow disintegration or dissolution if used in large amounts, especially insoluble fillers like dicalcium phosphate. This may lead to slower onset of action or reduced bioavailability.

25
New cards

Explain how the use of an excessive amount of filler in a pharmaceutical formulation can lead to reduced bioavailability of the drug.

Excessive use of filler in a pharmaceutical formulation can reduce the bioavailability of the drug due to the following reasons.

When too much filler is added, the proportion of the active drug in the dosage form decreases, which can affect the dissolution rate and the amount of drug available for absorption.

Some fillers, especially insoluble ones like dicalcium phosphate, can slow down the disintegration and dissolution of the tablet or capsule. This delays drug release, reducing the rate at which the drug becomes available in the bloodstream.

Excess filler can affect the physical properties of the formulation such as porosity and wettability, further influencing drug release and bioavailability. In summary, using too much filler can impede the drug’s release and absorption, ultimately lowering its bioavailability and therapeutic effectiveness.